INDGN vs SYNGENE: Stock Comparison

Indegene Limited vs Syngene International Limited

Live data: 27 July 2026, 11:37 AM IST • Source: NSE and company filings

Syngene International Limited is the larger company by market capitalisation. Indegene Limited shows a lower P/E, a higher ROE and faster revenue growth, while Syngene International Limited shows a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Indegene Limited and Syngene International Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, INDGN is more favourable on 9 of 13 scored metrics and SYNGENE on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
SYNGENE is the larger company
₹16,611 Cr vs ₹12,095 Cr
P/E Ratio
INDGN has a lower P/E
29.69x vs 51.65x
P/B Ratio
SYNGENE has a lower P/B
3.38x vs 3.79x
EPS
INDGN has higher earnings per share
₹16.6 vs ₹7.86
Dividend Yield
SYNGENE has a higher dividend yield
0.6% vs 0.46%
Revenue Growth (TTM YoY)
INDGN has faster revenue growth
32.8% vs 1.8%
EPS Growth (TTM YoY)
SYNGENE has faster EPS growth
-19.5% vs -32.3%
Qtr Sales Growth
INDGN has stronger quarterly sales growth
32.8% vs 10.7%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricINDGNSYNGENE
SectorHealthcareHealthcare
IndustryHealthcare Research Analytics & TechnologyHealthcare Research Analytics & Technology

Price

MetricINDGNSYNGENE
Live Price₹502.25₹412.6
Day Change1.95%1.46%
Volume35,0522.38 L
52-Week High₹596.8₹728.6
52-Week Low₹414₹380
Distance from 52W High-15.84%-43.37%

Valuation

MetricINDGNSYNGENE
Market Cap₹12,095 Cr₹16,611 Cr
P/E Ratio29.69x51.65x
P/B Ratio3.79x3.38x
EPS₹16.6₹7.86
Book Value₹130.29₹120.41
Dividend Yield0.46%0.6%

Growth

MetricINDGNSYNGENE
Revenue Growth (TTM YoY)32.8%1.8%
EPS Growth (TTM YoY)-32.3%-19.5%
Qtr Sales Growth32.8%10.7%
Qtr Profit Growth-19.1%67.4%

Profitability & Leverage

MetricINDGNSYNGENE
ROE14.4%6.62%
ROCE18.8%13.5%
Net Margin12.03%11.26%
Operating Margin17.6%17.52%
Debt to Equity0.05x9.47x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricINDGNSYNGENE
Promoter Holding52.59% 0.09 pp
FII Holding9.91% 0.36 pp11.82% 2.08 pp
DII Holding8.74% 0.44 pp28.02% 1.58 pp
Public Holding81.34% 0.1 pp7.14% 0.45 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Indegene Limited and Syngene International Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.